PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease.


Journal

BMC molecular and cell biology
ISSN: 2661-8850
Titre abrégé: BMC Mol Cell Biol
Pays: England
ID NLM: 101741148

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 18 12 2019
accepted: 20 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 30 12 2020
Statut: epublish

Résumé

Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation. Here, we show that mutagenic manipulation of PGRMC1 phosphorylation alters cell metabolism, genomic stability, and CpG methylation. Each of several mutants elicited distinct patterns of genomic CpG methylation. Mutation of S57A/Y180/S181A led to increased net hypermethylation, reminiscent of embryonic stem cells. Pathways enrichment analysis suggested modulation of processes related to animal cell differentiation status and tissue identity, as well as cell cycle control and ATM/ATR DNA damage repair regulation. We detected different genomic mutation rates in culture. A companion manuscript shows that these cell states dramatically affect protein abundances, cell and mitochondrial morphology, and glycolytic metabolism. We propose that PGRMC1 phosphorylation status modulates cellular plasticity mechanisms relevant to early embryological tissue differentiation.

Sections du résumé

BACKGROUND BACKGROUND
Progesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation.
RESULTS RESULTS
Here, we show that mutagenic manipulation of PGRMC1 phosphorylation alters cell metabolism, genomic stability, and CpG methylation. Each of several mutants elicited distinct patterns of genomic CpG methylation. Mutation of S57A/Y180/S181A led to increased net hypermethylation, reminiscent of embryonic stem cells. Pathways enrichment analysis suggested modulation of processes related to animal cell differentiation status and tissue identity, as well as cell cycle control and ATM/ATR DNA damage repair regulation. We detected different genomic mutation rates in culture.
CONCLUSIONS CONCLUSIONS
A companion manuscript shows that these cell states dramatically affect protein abundances, cell and mitochondrial morphology, and glycolytic metabolism. We propose that PGRMC1 phosphorylation status modulates cellular plasticity mechanisms relevant to early embryological tissue differentiation.

Identifiants

pubmed: 32293262
doi: 10.1186/s12860-020-00268-z
pii: 10.1186/s12860-020-00268-z
pmc: PMC7160964
doi:

Substances chimiques

Membrane Proteins 0
PGRMC1 protein, human 0
Receptors, Progesterone 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

26

Subventions

Organisme : Charles Sturt University (AU)
ID : N/A
Organisme : Iraqi Cultural Attaché in Canberra (AUS)
ID : N/A
Organisme : Australian Research Council (AU)
ID : CE140100003
Organisme : Australian Research Council (AU)
ID : DE120102687
Organisme : Ramaciotti Foundations
ID : ES2012/0051

Références

Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Biophys J. 2002 May;82(5):2811-25
pubmed: 11964266
Adv Biol Regul. 2017 Aug;65:5-15
pubmed: 28712664
Pharmacol Ther. 2009 Jan;121(1):14-9
pubmed: 18992768
Phys Biol. 2016 May 11;13(3):031001
pubmed: 27172135
Genome Biol. 2002;3(12):RESEARCH0068
pubmed: 12537557
Mol Pharmacol. 2011 Mar;79(3):340-50
pubmed: 21081644
Nat Chem Biol. 2013 Nov;9(11):693-700
pubmed: 24077178
Biol Reprod. 2014 Nov;91(5):104
pubmed: 25253729
Front Pharmacol. 2017 Mar 27;8:159
pubmed: 28396637
Org Biomol Chem. 2015 Jun 28;13(24):6686-9
pubmed: 26006184
BMC Mol Cell Biol. 2020 Apr 3;21(1):24
pubmed: 32245408
Biochim Biophys Acta. 2016 Jan;1863(1):56-63
pubmed: 26431992
Reproduction. 2018 Mar;155(3):273-282
pubmed: 29339453
Nat Commun. 2016 Mar 18;7:11030
pubmed: 26988023
Biochem Biophys Res Commun. 2020 Mar 26;524(1):64-69
pubmed: 31980178
J Neuroendocrinol. 2013 Nov;25(11):991-1001
pubmed: 23763432
Biochim Biophys Acta. 2016 Dec;1866(2):339-349
pubmed: 27452206
Pharmacol Ther. 2018 Aug;188:140-154
pubmed: 29577959
Cell Metab. 2015 Jul 7;22(1):31-53
pubmed: 26118927
PLoS One. 2014 Nov 12;9(11):e111899
pubmed: 25390692
Chem Commun (Camb). 2014 Aug 4;50(60):8181-4
pubmed: 24926565
Cell Div. 2018 Nov 10;13:8
pubmed: 30455725
Oncotarget. 2017 Aug 2;8(42):72480-72493
pubmed: 29069804
Eukaryot Cell. 2003 Apr;2(2):306-17
pubmed: 12684380
Nature. 2019 Dec;576(7785):138-142
pubmed: 31748741
J Biol Chem. 2004 Dec 3;279(49):50754-63
pubmed: 15381699
J Steroid Biochem Mol Biol. 2007 Jun-Jul;105(1-5):16-36
pubmed: 17583495
Sci Rep. 2018 Nov 15;8(1):16845
pubmed: 30443021
Biochem Pharmacol. 2019 May;163:481-492
pubmed: 30753815
Nat Ecol Evol. 2018 Sep;2(9):1358-1376
pubmed: 30135501
J Steroid Biochem Mol Biol. 2017 Jul;171:11-33
pubmed: 28104494
Nat Methods. 2005 Apr;2(4):261-7
pubmed: 15782218
Bioinformatics. 2007 Jan 15;23(2):257-8
pubmed: 17098774
Neuroscience. 2004;126(2):325-34
pubmed: 15207350
Arch Biochem Biophys. 2014 Dec 15;564:52-66
pubmed: 25201588
J Pharmacol Exp Ther. 2010 May;333(2):564-73
pubmed: 20164297
Proteomics. 2005 Apr;5(6):1472-80
pubmed: 15798990
Drug Metab Dispos. 2011 Nov;39(11):2057-65
pubmed: 21825115
Sci Rep. 2019 Jan 24;9(1):653
pubmed: 30679694
Steroids. 2012 Aug;77(10):1007-12
pubmed: 22326699
Nat Med. 2015 Aug;21(8):887-94
pubmed: 26168293
Endocrinology. 2008 Feb;149(2):534-43
pubmed: 17991724
Sci Rep. 2018 Feb 14;8(1):3016
pubmed: 29445118
Trends Endocrinol Metab. 2017 May;28(5):340-353
pubmed: 28291578
Cancer Lett. 2015 Jan 28;356(2 Pt B):434-42
pubmed: 25304370
Cell Cycle. 2016 Aug 2;15(15):2019-32
pubmed: 27260975
Cell Metab. 2016 Jun 14;23(6):965-966
pubmed: 27304496
Cell Cycle. 2016 Sep;15(17):2239-40
pubmed: 27355272
Horm Metab Res. 2017 Aug;49(8):595-603
pubmed: 28701017
Biochem J. 2011 May 15;436(1):145-55
pubmed: 21352099
Development. 2017 Oct 1;144(19):3392-3404
pubmed: 28974637
JCI Insight. 2017 May 18;2(10):
pubmed: 28515364
Cell Mol Life Sci. 2018 Jun;75(11):2011-2026
pubmed: 29119230
Mol Cell Biol. 2005 Mar;25(5):1669-79
pubmed: 15713626
Nat Chem Biol. 2013 May;9(5):300-6
pubmed: 23455543
Oncotarget. 2016 Aug 9;7(32):50822-50827
pubmed: 27448967
Dev Dyn. 2007 Apr;236(4):1144-56
pubmed: 17304537
Mol Phylogenet Evol. 2020 Apr 8;:106814
pubmed: 32278076
J Biomed Opt. 2014 Jan;19(1):10901
pubmed: 24441941
Nature. 2014 Apr 10;508(7495):258-62
pubmed: 24717514
Biochem Soc Trans. 2006 Dec;34(Pt 6):1303-6
pubmed: 17073807
PLoS Genet. 2018 Sep 7;14(9):e1007561
pubmed: 30192747
J Cell Biochem. 2003 Oct 15;90(3):534-47
pubmed: 14523988
Biol Reprod. 2014 Aug;91(2):36
pubmed: 24990806
J Cell Sci. 2012 Oct 15;125(Pt 20):4833-40
pubmed: 22854044
Sci Rep. 2016 Mar 31;6:23453
pubmed: 27029742
Nat Cell Biol. 2015 Dec;17(12):1523-35
pubmed: 26571212
Cell Metab. 2007 Feb;5(2):143-9
pubmed: 17276356
Sci Rep. 2018 Feb 14;8(1):3048
pubmed: 29445107
Climacteric. 2009 Jun;12(3):230-9
pubmed: 19340614
Bioinformatics. 2017 Sep 15;33(18):2938-2940
pubmed: 28645171
Life Sci. 2019 Aug 15;231:116541
pubmed: 31216441
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
Exp Gerontol. 2014 Jan;49:5-11
pubmed: 24184118
Nat Commun. 2016 May 27;7:11694
pubmed: 27229764
Biochemistry. 2016 Sep 20;55(37):5204-17
pubmed: 27599036
Reproduction. 2014 Apr 08;147(5):R169-78
pubmed: 24516175
Front Cell Neurosci. 2017 Feb 01;11:14
pubmed: 28203146
Biosci Trends. 2017 May 23;11(2):179-192
pubmed: 28250339
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
Hum Cell. 2016 Jul;29(3):97-100
pubmed: 27083573
Cancer Biol Ther. 2016;17(3):262-71
pubmed: 26785864
Breast Cancer Res. 2008;10(5):R85
pubmed: 18922159
Cold Spring Harb Perspect Biol. 2012 Nov 01;4(11):
pubmed: 23024173
Cell Mol Life Sci. 2015 Jun;72(12):2395-409
pubmed: 25596698
Ageing Res Rev. 2014 Jul;16:66-82
pubmed: 24910306

Auteurs

Bashar M Thejer (BM)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Department of Biology, College of Science, University of Wasit, Kut, Wasit, Iraq.

Partho P Adhikary (PP)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Present Address: Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada.

Sarah L Teakel (SL)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

Johnny Fang (J)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

Paul A Weston (PA)

Graham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
School of Agricultural and Wine Sciences, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.

Saliya Gurusinghe (S)

Graham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.

Ayad G Anwer (AG)

ARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Present Address: The Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Kensington, NSW, 2052, Australia.

Martin Gosnell (M)

ARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Quantitative (Biotechnology) Pty. Ltd., ABN 17 165 684 186, Australia.

Jalal A Jazayeri (JA)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

Marina Ludescher (M)

Department of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.

Lesley-Ann Gray (LA)

Australian Genome Research Facility Ltd., Victorian Comprehensive Cancer Centre, Melbourne, VIC, 3000, Australia.

Michael Pawlak (M)

NMI TT Pharmaservices, Protein Profiling, 72770 Reutlingen, Germany.

Robyn H Wallace (RH)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.

Sameer D Pant (SD)

School of Animal and Veterinary Sciences, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.

Marie Wong (M)

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.

Tamas Fischer (T)

ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.

Elizabeth J New (EJ)

University of Sydney, School of Chemistry, Sydney, NSW, 2006, Australia.

Tanja N Fehm (TN)

Department of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.

Hans Neubauer (H)

Department of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.

Ewa M Goldys (EM)

ARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Present Address: The Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Kensington, NSW, 2052, Australia.

Jane C Quinn (JC)

Graham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Faculty of Science, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.

Leslie A Weston (LA)

Graham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
School of Agricultural and Wine Sciences, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.

Michael A Cahill (MA)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia. mcahill@csu.edu.au.
ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia. mcahill@csu.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH